Heterocyclic Compounds as Dipeptidyl Peptidase-IV Inhibitors with Special Emphasis on Oxadiazoles as Potent Anti-Diabetic Agents

Heterocyclic Compounds as Dipeptidyl Peptidase-IV Inhibitors with Special Emphasis on Oxadiazoles as Potent Anti-Diabetic Agents

Dipeptidyl peptidase-IV (DPP-IV) inhibitors, often known as gliptins, have been used to treat type 2 diabetes mellitus (T2DM). They may be combined with other medications as an additional treatment or used alone as a monotherapy. In addition to insulin, sulfonylureas, thiazolidinediones, and metform...

Full description

Bibliographic Details
Main Authors: Badrud Duza Mohammad, Mirza Shahed Baig, Neeraj Bhandari, Falak A. Siddiqui, Sharuk L. Khan, Zubair Ahmad, Farhat S. Khan, Priti Tagde, Philippe Jeandet
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Molecules
Subjects:
oxadiazole
sulfonylureas
DPP-IV inhibitors
diabetes mellitus
peptidomimetics
Online Access:https://www.mdpi.com/1420-3049/27/18/6001

Internet

https://www.mdpi.com/1420-3049/27/18/6001

Similar Items